Our 800 patient validation trial is entering the final phase of inclusion and the first preliminary results are expected in August. In the meantime we are in discussion with several potential development partners. Jack van Lint our CEO will be visiting Digestive Disease Week 2022 in San Diego this weekend so if you are there reach out to him!
